Avoro Capital Advisors LLC Q4 2021 Filing
Filed February 14, 2022
Portfolio Value
$5.9T
Holdings
40
Report Date
Q4 2021
Filing Type
13F-HR
All Holdings (40 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | HZNPHORIZON THERAPEUTICS PLC | 9,295,000 | $1.0T | 17.05% | |
| 2 | MRTXEURMIRATI THERAPEUTICS INC | 5,075,000 | $744.5B | 12.67% | |
| 3 | UTHUNITED THERAPEUTICS CORP | 3,035,000 | $655.8B | 11.16% | |
| 4 | APLSAPELLIS PHARMACEUTICALS INC | 8,555,555 | $404.5B | 6.88% | |
| 5 | ARGXARGENX SE | 965,000 | $337.9B | 5.75% | |
| 6 | SRPTSAREPTA THERAPEUTICS INC | 3,425,000 | $284.3B | 4.84% | Call |
| 7 | ASNDASCENDIS PHARMA | 2,000,000 | $269.1B | 4.58% | |
| 8 | BMRNBIOMARIN PHARMACEUTICAL INC | 2,800,000 | $247.4B | 4.21% | |
| 9 | AM6AMICUS THERAPEUTICS INC | 18,500,000 | $213.7B | 3.64% | |
| 10 | ALNYALNYLAM PHARMACEUTICALS INC | 1,075,000 | $182.3B | 3.10% | |
| 11 | IOVAIOVANCE BIOTHERAPEUTICS INC | 8,675,000 | $165.6B | 2.82% | |
| 12 | XENEXENON PHARMACEUTICALS INC | 4,985,000 | $155.7B | 2.65% | |
| 13 | OPHTEURIVERIC BIO INC | 7,250,000 | $121.2B | 2.06% | |
| 14 | MDGLMADRIGAL PHARMACEUTICALS INC | 1,425,000 | $120.8B | 2.06% | |
| 15 | XBISPDR SERIES TRUST - S&P BIOTECH | 1,050,000 | $117.6B | 2.00% | |
| 16 | ARNAEURARENA PHARMACEUTICALS INC | 1,235,000 | $114.8B | 1.95% | |
| 17 | GLUEMONTE ROSA THERAPEUTICS INC | 3,311,434 | $67.6B | 1.15% | |
| 18 | KURAKURA ONCOLOGY INC | 4,000,000 | $56.0B | 0.95% | |
| 19 | ACADACADIA PHARMACEUTICALS INC | 2,200,000 | $51.3B | 0.87% | |
| 20 | SNDXSYNDAX PHARMACEUTICALS INC | 2,175,000 | $47.6B | 0.81% | |
| 21 | WHWKAADI BIOSCIENCES INC | 1,829,402 | $44.2B | 0.75% | |
| 22 | —MERSANA THERAPEUTICS INC | 6,800,000 | $42.3B | 0.72% | |
| 23 | MNKDMANNKIND CORP | 8,800,000 | $38.5B | 0.65% | |
| 24 | MRNS*MARINUS PHARMACEUTICALS INC | 3,235,000 | $38.4B | 0.65% | |
| 25 | PRAXPRAXIS PRECISION MEDICINES INC | 1,780,000 | $35.1B | 0.60% | |
| 26 | DSGNDESIGN THERAPEUTICS INC | 1,636,100 | $35.0B | 0.60% | |
| 27 | KYMRKYMERA THERAPEUTICS INC | 550,000 | $34.9B | 0.59% | |
| 28 | CBAYUSDCYMABAY THERAPEUTICS INC | 10,300,000 | $34.8B | 0.59% | |
| 29 | PMVPPMV PHARMACEUTICALS INC | 1,465,000 | $33.8B | 0.58% | |
| 30 | KRYSKRYSTAL BIOTECH INC | 475,000 | $33.2B | 0.57% | |
| 31 | RNAAVIDITY BIOSCIENCES INC | 1,230,000 | $29.2B | 0.50% | |
| 32 | AMRNAMARIN CORP PLC | 6,000,000 | $20.2B | 0.34% | |
| 33 | NUVLNUVALENT INC | 1,102,671 | $18.4B | 0.31% | |
| 34 | TNGXTANGO THERAPEUTICS INC | 1,550,000 | $17.0B | 0.29% | |
| 35 | —DICE THERAPEUTICS INC | 562,500 | $14.2B | 0.24% | |
| 36 | AVDLAVADEL PHARMACEUTICALS PLC | 1,670,000 | $13.5B | 0.23% | |
| 37 | ADVMCHFADVERUM BIOTECHNOLOGIES INC | 6,950,000 | $12.2B | 0.21% | |
| 38 | IOBTIO BIOTECH INC | 2,055,883 | $10.2B | 0.17% | |
| 39 | GNCAQGENOCEA BIOSCIENCES INC | 5,084,184 | $5.9B | 0.10% | |
| 40 | FRXFENNEC PHARMACEUTICALS INC | 1,200,000 | $5.3B | 0.09% |